Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertension

In patients with complex congenital heart disease (CHD) pathogenic SMAD6 variants have been described previously. The aim of this study was to analyze if pathogenic SMAD6 variants also occur in patients with CHD associated with pulmonary arterial hypertension (CHD-APAH) or idiopathic PAH. A PAH gene panel with up to 64 genes including SMAD6 was used to sequence 311 patients with idiopathic PAH (IPAH) and 32 with CHD-APAH. In 4 of 32 (12.5%) CHD-APAH and in 2 out of 311 (0.64%) IPAH patients we identified likely pathogenic or rare SMAD6 missense variants. All CHD-APAH patients with a rare SMAD6 variant had complex CHD. One patient had bi-allelic SMAD6 variants, combined pulmonary valve defect and supravalvular aortic stenosis, craniosynostosis and radioulnar synostosis. This is the first description of potentially disease-causing SMAD6 variants in patients with IPAH and complex CHD-APAH. Further studies are needed to assess pathogenesis and prevalence of pathogenic SMAD6 variants in PAH.

Authors

Institutions

Publication Details

Journal
npj Genomic Medicine
Published
2025-03-25
DOI
https://doi.org/10.1038/s41525-025-00484-6
Citations
3
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
4.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertension

Jan C. Kamp, Ralf Ewert, Marius M. Hoeper, Panagiota Xanthouli et al.
3 citations
npj Genomic Medicine
Pulmonary Hypertension Research and Treatments
4.56
article

Pathogenic SMAD6 variants in patients with idiopathic and complex congenital heart disease associated pulmonary arterial hypertension

Jan C. Kamp, Ralf Ewert, Marius M. Hoeper, Panagiota Xanthouli, Katrin Milger, Christina A. Eichstaedt, Michael Halank, Ralf Geiger, Christian Apitz, Memoona Shaukat, Fabian von Scheidt, Matthias Held, Hans F. E. Klose, Horst Olschewski, Ekkehard Grünig, Benjamin Egenlauf, Katrin Hinderhofer, Gábor Kovács, S. R. Karl, Karen M. Olsson, Hans-Jürgen Seyfarth
article en
3 citations

Abstract

In patients with complex congenital heart disease (CHD) pathogenic SMAD6 variants have been described previously. The aim of this study was to analyze if pathogenic SMAD6 variants also occur in patients with CHD associated with pulmonary arterial hypertension (CHD-APAH) or idiopathic PAH. A PAH gene panel with up to 64 genes including SMAD6 was used to sequence 311 patients with idiopathic PAH (IPAH) and 32 with CHD-APAH. In 4 of 32 (12.5%) CHD-APAH and in 2 out of 311 (0.64%) IPAH patients we identified likely pathogenic or rare SMAD6 missense variants. All CHD-APAH patients with a rare SMAD6 variant had complex CHD. One patient had bi-allelic SMAD6 variants, combined pulmonary valve defect and supravalvular aortic stenosis, craniosynostosis and radioulnar synostosis. This is the first description of potentially disease-causing SMAD6 variants in patients with IPAH and complex CHD-APAH. Further studies are needed to assess pathogenesis and prevalence of pathogenic SMAD6 variants in PAH.

npj Genomic MedicineVol. 10(1)
Innsbruck Medical University (AT), Universität Hamburg (DE), Medical University of Graz (AT), Heidelberg University (DE), Universitätsmedizin Greifswald (DE), University Hospital Heidelberg (DE), Medizinische Hochschule Hannover (DE), Universität Greifswald (DE), Ludwig Boltzmann Institute for Lung Vascular Research (AT), University Medical Center Hamburg-Eppendorf (DE), Institute of Human Genetics (PL), Asklepios Fachkliniken München-Gauting (DE), University Hospital Leipzig (DE), German Center for Lung Research (DE), Klinikum Würzburg Mitte (DE), Deutsches Herzzentrum München (DE), University Hospital Ulm (DE), University Hospital Carl Gustav Carus (DE), Technische Universität Dresden (DE), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 6%
Pulmonary Hypertension Research and Treatments
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.